U.S. markets close in 1 hour 45 minutes
  • S&P 500

    4,108.40
    -0.91 (-0.02%)
     
  • Dow 30

    33,543.68
    +269.53 (+0.81%)
     
  • Nasdaq

    12,102.77
    -119.14 (-0.97%)
     
  • Russell 2000

    1,791.52
    -10.97 (-0.61%)
     
  • Crude Oil

    80.35
    +4.68 (+6.18%)
     
  • Gold

    2,001.70
    +15.50 (+0.78%)
     
  • Silver

    24.03
    -0.13 (-0.52%)
     
  • EUR/USD

    1.0894
    +0.0047 (+0.44%)
     
  • 10-Yr Bond

    3.4340
    -0.0600 (-1.72%)
     
  • GBP/USD

    1.2402
    +0.0070 (+0.56%)
     
  • USD/JPY

    132.3550
    -0.4420 (-0.33%)
     
  • Bitcoin USD

    27,999.65
    -201.30 (-0.71%)
     
  • CMC Crypto 200

    614.99
    +8.57 (+1.41%)
     
  • FTSE 100

    7,673.00
    +41.26 (+0.54%)
     
  • Nikkei 225

    28,188.15
    +146.67 (+0.52%)
     

Transcatheter Heart Valve Replacement and Repair Market to Reach USD 8.0 Bn by 2031 | TMR Study

WILMINGTON, DE / ACCESSWIRE / April 3, 2023 / Transparency Market Research Inc. - The global transcatheter heart valve replacement and repair market was valued at USD 3.4 Bn in 2022 and is projected to reach USD 8.0 Bn by 2031 with CAGR of 9.7% from 2023 to 2031.

Transparency Market Research inc., Monday, April 3, 2023, Press release picture
Transparency Market Research inc., Monday, April 3, 2023, Press release picture

Rise in demand for transcatheter heart valve replacement and repair procedures to treat severe aortic stenosis is expected to accelerate market development.

Request for a Sample PDF Copy with Latest Industry Insights at https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=50511

Market Snapshot:

Report Coverage

Details

Market Revenue

USD 3.4 Bn in 2022

Estimated Value

USD 8.0 Bn by 2031

Growth Rate

9.7%

Forecast Period

2023-2031

No. of Pages

235 Pages

Market Segmentation

By Procedure, Indication and End-user

Regions Covered

North America, Europe, Asia Pacific, Middle East & Africa, South America

Companies Covered

Abbott Laboratories, Edwards Lifesciences Corporation, Medtronic plc, Boston Scientific Corporation, JenaValve Technology, Inc., Meril Life Sciences, Sahajanand Medical Technologies Limited, MicroPort Scientific Corporation, Venus Medtech (Hangzhou), Inc., Suzhou Jiecheng Medical Technology Co. Ltd., Peijia Medical Limited, and Blue Sail Medical Co., Ltd.

Advancements in transcatheter aortic valve implantation technologies have led to development of devices, which are easy to implant and retrieve, thereby enhancing the long-term outcomes and safety of these procedures. A case in point is innovation in mechanical pulmonary valve replacement techniques. High prevalence of severe aortic stenosis in the elderly population presents significant business opportunities to companies in the transcatheter heart valve replacement and repair industry.

Key Findings of Study

  • Significant Adoption of Transcatheter Aortic Valve Replacement to Offer Lucrative Opportunities: Surge in preference for transcatheter aortic valve replacement over open heart surgeries is likely to bolster the market. Transcatheter aortic valve replacement is an emerging segment. It held leading market share in 2022. Rise in adoption of transcatheter aortic valve replacement to treat severe aortic stenosis is likely to propel the segment. These are widely performed in hospitals settings. Hence, the hospitals segment accounted for major share in 2022. Increase in preference for hospitals among patients could be ascribed to availability of advanced treatments, comprehensive post-procedural care, and better patient selection criteria.

  • Advancements in Transcatheter Heart Valve Technologies and Techniques to Boost Market: Rise in demand for minimally invasive surgical approaches to treat structural heart diseases has encouraged R&D activities in transcatheter heart valve technologies. Introduction of new devices for transcatheter aortic valve implantation is likely to bolster market development during the forecast period.

Key Drivers

  • High prevalence of valvular heart diseases is a key driver of the transcatheter heart valve replacement and repair market. Preference for minimally invasive interventions to treat valvular heart disease, such as congenital pulmonary stenosis and severe aortic stenosis, is likely to augment market size.

  • Surge in incidence of cardiovascular diseases is expected to bolster demand for transcatheter heart valve replacement procedures. Demand for such procedures has increased rapidly in developed and developing countries in the past few years owing to advancements in medical technologies used in aortic valve replacement. Introduction of new devices has led to better long-term outcomes of transcatheter heart valve replacement and repair procedures in high-risk patients with severe aortic stenosis.

  • Rise in number of congenital heart disease in adults is expected to fuel demand for TAVR procedures

To Receive Tailored Service, Please Share Your Research Needs: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=50511

Regional growth Dynamics

North America accounted for leading share of the global transcatheter heart valve replacement and repair market in 2022. Favorable reimbursement framework, such as Medicare and Medicaid, in the U.S. is likely to encourage patients to undergo TAVR. Surge in prevalence of valvular heart diseases in the region is anticipated to fuel the market growth from 2023 to 2031.

Europe is also a lucrative transcatheter heart valve replacement and repair market. France, Germany, and the U.K. are anticipated to offer significant opportunities to companies in the region. Rapidly aging population in Europe is likely to propel the demand for transcatheter heart valve replacement and repair procedures in the near future.

The market in Asia Pacific is anticipated to grow at a rapid pace from 2023 to 2031. Improvements in healthcare infrastructure and rise in awareness about the burden of valvular heart diseases and congenital heart diseases are expected to propel the market. Japan and China are lucrative markets, likely to be driven by rise in demand for transcatheter heart valve replacement and repair procedures in the elderly population.

Competition Landscape

Leading players are focusing on product portfolio expansion and merger and acquisition in order to increase revenue during the forecast period. Prominent companies are keen on medical innovations to treat structural heart diseases in a bid to consolidate their market positions.

Some of the key players operating in the market are Abbott Laboratories, Edwards Lifesciences, Medtronic Plc., Boston Scientific Corporation, JenaValve, Meril, MicroPort, Venus MedTech Hangzhou Inc., Peijia Medical, Blue Sail Medical Co., Ltd., and Sahajanand Medical Technologies Pvt. Ltd.

Browse the Full Report with Facts and Figures of the Transcatheter Heart Valve Replacement and Repair Market at: https://www.transparencymarketresearch.com/checkout.php?rep_id=50511<>

Transcatheter Heart Valve Replacement and Repair Market Segmentation

Procedure

  • Transcatheter Heart Valve Replacement

  • Transcatheter Mitral Valve Repair

  • Transcatheter Pulmonary Valve Replacement

Indication

  • Aortic Stenosis

  • Mitral Regurgitation

  • Aortic Regurgitation

  • Mitral Stenosis

  • Tricuspid Regurgitation

End-user

  • Hospitals

  • Ambulatory Surgical Centers

  • Cardiac Catheterization Laboratories

Region

  • North America

  • Europe

  • Latin America

  • Asia Pacific

  • Middle East & Africa

Stay Updated with Latest Healthcare Industry Research Reports:

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

SOURCE: Transparency Market Research inc.



View source version on accesswire.com:
https://www.accesswire.com/747260/Transcatheter-Heart-Valve-Replacement-and-Repair-Market-to-Reach-USD-80-Bn-by-2031-TMR-Study